ACE2 and COVID-19: Nevertheless, more studies are required to confirm the therapeutic role of the soluble catalytic ectodomain of ACE2 in COVID-19, as well the ACE2 expression, and ACE2 plasma activity levels, and their prognostic significance needs, to be clarified with further studies.